CIK 0001410098
- Non-accelerated filer
CorMedix Inc.
Sign in to watch- Ticker
- CRMD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 908-517-9500
- Business address
- 389 INTERPACE PKWY, SUITE 450, PARSIPPANY, NJ, 07054
- 4 Shares withheld for taxes Chief Executive Officer gave up 40,082 shares (to pay taxes)
- 4 Grant or award Chief Commercial Officer acquired 133,156 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Exercise or conversion Director acquired 15,000 shares (option exercise)
- 4 Shares withheld for taxes Chief Operating Officer gave up 10,895 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Legal Officer gave up 11,333 shares (to pay taxes)
- 4 Planned sale Director sold 20,000 shares at $13.00 ($260,000)
- 4 Planned sale Chief Executive Officer sold 30,000 shares at $12.00 ($360,000)
- 4 Planned sale Director sold 34,000 shares at $12.00 ($408,000)
- 4 Open-market sale Director sold 40,000 shares at $11.88 ($475,200)
- 4 Planned sale Director sold 46,657 shares at $10.00 ($466,570)
- 4 Open-market sale Director sold 26,343 shares at $9.93 ($261,586)
- 4 Open-market sale Director sold 30,000 shares at $11.42 ($342,600)
- 4 Open-market buy Director bought 25,000 shares at $11.02 ($275,500)
- 4 Exercise or conversion Director acquired 13,333 shares (option exercise)
- 4 Open-market sale Director sold 10,000 shares at $13.13 ($131,300)
- 4 Open-market sale Chief Executive Officer sold 50,000 shares at $13.00 ($650,000)
- 4 Shares withheld for taxes Chief Executive Officer gave up 21,225 shares (to pay taxes)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Legal Officer sold 50,000 shares at an average $13.41 ($670,264)
Page 2 of 26 · 512 filings